CEL-SCI Invited to Deliver Keynote Address on Multikine at 6th World Congress on Otology, Rhinology and Laryngology

CEL-SCI has been invited to deliver a keynote address on its Multikine cancer immunotherapy at the 6th World Congress on Otology, Rhinology and Laryngology. The announcement provides external visibility for Multikine but contains no clinical-trial results, regulatory updates, financial figures, or commercial milestones.